Food News and Research

RSS

First Edition: December 23, 2013

The early morning highlights from the major news organizations examine today's deadline for enrolling for health insurance that would begin Jan. 1, as well as a variety of other health law stories and several articles on mental health issues:

23 Dec 2013

ATS applauds NYC council for taking major step to protect public from risks linked with e-cigarettes

The American Thoracic Society, which has been based in New York City since 1905, is pleased with the city council vote yesterday prohibiting the use of electronic cigarettes in indoor public areas where smoking regular cigarettes is also banned.

23 Dec 2013

FDA grants QIDP and Fast Track designations to TaiGen's nemonoxacin

TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin (Taigexyn) Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

23 Dec 2013

Special combination of yoga and nutrition helps young cancer patients manage disease

At St. Jude Children's Research Hospital, the centuries-old practice of yoga is combined with nutrition education to help young cancer patients manage their disease today and lay the foundation for a healthy future.

23 Dec 2013

PAZ extracts may be useful option for improving plasma cholesterol profile

Health Enhancement Products, Inc., in conjunction with Wayne State University's Department of Nutrition and Food Science in the College of Liberal Arts and Sciences, announces the publication of a scientific article in the Journal of Nutrition & Metabolism, "ProAlgaZyme sub-fraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites."

22 Dec 2013

Lilly, Boehringer Ingelheim announce FDA acceptance of NDA filing for new insulin glargine product

Eli Lilly and Company and Boehringer Ingelheim today announced that the U.S. Food and Drug Administration has accepted the filing of the New Drug Application for LY2963016, an investigational basal (long-acting) insulin.

21 Dec 2013

Orenitram Extended-Release Tablets get FDA approval for pulmonary arterial hypertension treatment

United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Orenitram (treprostinil) Extended-Release Tablets for the treatment of pulmonary arterial hypertension in WHO Group I patients to improve exercise capacity.

21 Dec 2013

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.

20 Dec 2013

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration requesting approval of XIAFLEX (collagenase clostridium histolyticum, or CCH) for the treatment of multiple Dupuytren's contracture cords concurrently.

20 Dec 2013

New antibody could boost strength, muscle mass in patients with cancer and other diseases

A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease, sporadic inclusion body myositis, and in elderly patients with sarcopenia according to research published ahead of print in the journal Molecular and Cellular Biology.

20 Dec 2013

Adults nationwide concerned about use of e-cigarettes by children and teens

Adults nationwide are concerned about the use of e-cigarettes by children and teens, with 44 percent indicating worries that the devices will encourage kids to use tobacco products, according to a new poll from the University of Michigan.

20 Dec 2013

Article examines the health aspects of trans fat substitutes

Health advocates cheered last month's U.S. Food and Drug Administration (FDA) proposal to ban partially hydrogenated oils - which contain trans fats that increase the risk of heart disease - but some wonder whether the substitutes for these fats will be any healthier.

20 Dec 2013

Study finds milk serves as protective carrier of bioactive molecules

Polyphenols found in tea manifest anti-cancer effects but their use is limited by poor bioavailability and disagreeable taste. A new study in the Journal of Dairy Science- finds that when epigallocatechin gallate (EGCG), the major extractable polyphenol in green tea and the most biologically active, when diluted in skim milk or other milk complexes remains bioactive and continues to reduce colon cancer cell proliferation in culture at concentrations higher than 0.03 mg of EGCG/mL.

20 Dec 2013

Sugar-based gelators may provide alternatives to trans fats linked to obesity, heart disease, diabetes

Researchers at The City College of New York have reported the successful transformation of vegetable oils to a semisolid form using low-calorie sugars as a structuring agent.

20 Dec 2013

New American Journal of Public Health issue explores methods, practices to enhance birth outcomes

In a new issue of the American Journal of Public Health, researchers and experts investigate the latest methods and practices in improving birth outcomes. The special issue compiles a collection of commentaries, research studies and editorials to discuss maternal and child health topics ranging from disparities to breastfeeding.

20 Dec 2013

MicuRx announces initiation of global clinical development program for MRX-I compound

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the initiation of a global clinical development program for its lead compound MRX-I, a novel oxazolidinone antibiotic for treatment of Gram-positive infections including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.

20 Dec 2013

USC's Keck Medicine becomes world's first center to implant responsive brain device to treat epilepsy

On Dec. 18, Keck Medicine of USC became the world's first medical center to implant a responsive brain device newly approved by the Food and Drug Administration to treat epilepsy, with potential to help millions of people worldwide.

20 Dec 2013

Small changes to familiar combo meals can help cut calorie consumption

What would happen if a fast-food restaurant reduces the calories in a children's meal by 104 calories, mainly by decreasing the portion size of French fries? Would children compensate by choosing a more calorie dense entr-e or beverage? Researchers at Cornell University, Dr. Brian Wansink and Dr. Andrew Hanks, analyzed transaction data from 30 representative McDonald's restaurants to answer that question.

20 Dec 2013

Scientists propose reaction-diffusion model to study transmission of Lyme disease seasonally

Lyme disease is a common tick-borne illness caused by a bacterium, which is transmitted to humans through the bite of infected ticks. The transmission dynamics of Lyme disease is dependent on a variety of factors, including the length of the tick's life cycle, availability of hosts, climatic conditions and seasonal influences, which are important to understand for control strategies.

20 Dec 2013

New research assesses nanomedicine-based approaches for treating cancer

As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.

20 Dec 2013

Food News and Research

First Edition: December 23, 2013

ATS applauds NYC council for taking major step to protect public from risks linked with e-cigarettes

FDA grants QIDP and Fast Track designations to TaiGen's nemonoxacin

Special combination of yoga and nutrition helps young cancer patients manage disease

PAZ extracts may be useful option for improving plasma cholesterol profile

Lilly, Boehringer Ingelheim announce FDA acceptance of NDA filing for new insulin glargine product

Orenitram Extended-Release Tablets get FDA approval for pulmonary arterial hypertension treatment

Biocryst seeks FDA NDA approval for Peramivir to treat influenza

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

New antibody could boost strength, muscle mass in patients with cancer and other diseases

Adults nationwide concerned about use of e-cigarettes by children and teens

Article examines the health aspects of trans fat substitutes

Study finds milk serves as protective carrier of bioactive molecules

Sugar-based gelators may provide alternatives to trans fats linked to obesity, heart disease, diabetes

New American Journal of Public Health issue explores methods, practices to enhance birth outcomes

MicuRx announces initiation of global clinical development program for MRX-I compound

USC's Keck Medicine becomes world's first center to implant responsive brain device to treat epilepsy

Small changes to familiar combo meals can help cut calorie consumption

Scientists propose reaction-diffusion model to study transmission of Lyme disease seasonally

New research assesses nanomedicine-based approaches for treating cancer

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News